Status:
COMPLETED
BMS-562247 in Subjects Undergoing Elective Total Knee Replacement Surgery
Lead Sponsor:
Bristol-Myers Squibb
Conditions:
Venous Thrombosis
Pulmonary Embolism
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to learn if BMS-562247 can prevent blood clots in the legs and lungs in men and women following unilateral total knee replacement surgery. The safety of this treatment wil...
Eligibility Criteria
Inclusion
- Undergoing elective unilateral total knee replacement surgery.
- Willing and able to undergo bilateral ascending contrast venography.
- Able to inject (by self or caregiver) study medication subcutaneously.
Exclusion
- Women of childbearing potential.
- Women who are pregnant or breastfeeding.
- Under some conditions, subjects weighing more than 300 lbs. (136kg) and/or Body Mass Index (BMI) \>=35 kg/m2
Key Trial Info
Start Date :
October 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
1238 Patients enrolled
Trial Details
Trial ID
NCT00097357
Start Date
October 1 2004
End Date
December 1 2005
Last Update
March 2 2010
Active Locations (147)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Birmingham, Alabama, United States
2
Local Institution
Mobile, Alabama, United States
3
Local Institution
Northport, Alabama, United States
4
Local Institution
Phoenix, Arizona, United States